Women’s Health Medications - HRT, Fertility, and Hormone Therapy
Women experience unique health needs across the reproductive lifespan: menstrual cycle disorders, contraception, fertility, pregnancy, menopause, hormone-sensitive cancers, and bone health. This catalogue covers the full range of hormonal and reproductive medications beyond standard oral contraceptives (covered in Birth Control category). Modern women health pharmacotherapy combines hormone replacement, fertility induction, progesterone therapy, selective estrogen receptor modulators (SERMs), aromatase inhibitors, and bone-protective agents — each with specific indications and patient-fit considerations.
The category includes both generic and branded HRT options: estrogens (Premarin / conjugated estrogens, Estrace / oral estradiol, Progynova / estradiol valerate, Vagifem / vaginal estradiol), progestins for both cycle regulation and HRT (Provera / medroxyprogesterone, Aygestin / norethindrone, Duphaston / dydrogesterone, Gestanin / allylestrenol, Susten / progesterone), fertility agents (Clomid / clomiphene with multiple generics, Femara / letrozole, Dostinex / cabergoline, Parlodel / bromocriptine), bone health agents (Fosamax / alendronate, Evista / raloxifene), and women-specific PDE5 inhibitors (Lovegra, Femalefil).
Choosing the right medication depends on specific diagnosis, age, fertility goals, menopausal status, breast cancer history, cardiovascular risk, bone density status, and individual values. Many of these agents require specialist supervision — gynaecology, endocrinology, or oncology — particularly for fertility induction, HRT initiation, and post-cancer surveillance.
🧑🦵 Conditions This Category Treats
Menopausal symptoms — hot flushes, night sweats, sleep disturbance, mood changes, vaginal dryness, dyspareunia (painful sex), reduced libido — affect the majority of women during perimenopause and early menopause. Systemic HRT with estrogen (combined with progestin for women with intact uterus to prevent endometrial cancer) effectively treats moderate-to-severe symptoms. Options include oral (Premarin / Estrace / Progynova), transdermal (patches, gels), and combined estrogen-progestin formulations. Local vaginal estrogen (Vagifem) treats genitourinary syndrome of menopause without significant systemic exposure — suitable for women who prefer not to use systemic HRT.
Menstrual cycle disorders and uterine bleeding: Progestins (Provera, Aygestin, Duphaston) regulate cycles, treat anovulatory bleeding, manage endometrial hyperplasia, and support luteal phase. Functional ovarian cysts are reduced by combined hormonal contraceptive. Polycystic ovary syndrome (PCOS) often requires combined therapy: combined oral contraceptive for cycles, metformin for insulin resistance, spironolactone for androgenic features.
Infertility: Clomid / clomiphene (with generics Clofert, Fertomid) is first-line for anovulatory infertility (often PCOS-related), inducing ovulation in 70-80% of treated cycles. Letrozole (Femara) is also FDA approved for ovulation induction and may be preferred in PCOS-related infertility. Dostinex (cabergoline) and Parlodel (bromocriptine) treat hyperprolactinaemia (high prolactin causing menstrual irregularity, galactorrhea, or infertility). Susten (progesterone) supports luteal phase in fertility cycles and pregnancy maintenance.
Bone health: Fosamax (alendronate) — the most-prescribed bisphosphonate — treats and prevents postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, and male osteoporosis. Evista (raloxifene) is a SERM that protects bone, reduces breast cancer risk, but causes hot flushes. Sexual dysfunction: women-specific PDE5 inhibitors (Lovegra Oral Jelly, Femalefil) have been marketed for female sexual arousal disorder, though evidence for this indication is less robust than for male erectile dysfunction.
💊 How Modern Women's Health Treatment Works
Estrogens bind to estrogen receptors throughout the body, replicating physiological actions. Premarin (conjugated equine estrogens) is the historical gold standard with most evidence; modern alternatives like Estrace (estradiol), Progynova (estradiol valerate), and transdermal patches provide similar benefits with potentially lower thromboembolic risk via transdermal route. Vagifem (vaginal estradiol) achieves high local concentrations with minimal systemic absorption — suitable for women with isolated vaginal symptoms or contraindications to systemic estrogen.
Progestins oppose estrogen effects on the endometrium (preventing hyperplasia and cancer in women with intact uterus on systemic estrogen) and have specific actions in cycle regulation, pregnancy support, and contraception. Medroxyprogesterone (Provera) is the most-prescribed; norethindrone (Aygestin), dydrogesterone (Duphaston), allylestrenol (Gestanin), and progesterone (Susten) are alternatives with slightly different receptor profiles and side effect patterns.
Clomiphene blocks estrogen receptors at the hypothalamus, releasing the negative feedback that normally limits FSH/LH release. The resulting increased gonadotropin stimulates ovarian follicle development. Letrozole (Femara) is an aromatase inhibitor — it blocks estrogen synthesis, similarly disinhibiting gonadotropin release. Both produce ovulation in 70-80% of anovulatory women; multiple gestation rates are moderate (5-10%). Bromocriptine (Parlodel) and cabergoline (Dostinex) are dopamine agonists that suppress prolactin secretion, treating hyperprolactinaemia from prolactinomas or idiopathic causes. Alendronate (Fosamax) inhibits osteoclast activity, reducing bone resorption and improving bone density; oral dosing requires careful adherence to administration instructions to avoid oesophageal irritation.
💊 Drug Classes in This Category
| Class | Best For | Examples |
|---|---|---|
| Systemic estrogens (HRT) | Menopausal symptoms, premature ovarian insufficiency, surgical menopause | Premarin, Estrace, Progynova |
| Vaginal estrogen | Genitourinary syndrome of menopause; isolated vaginal symptoms | Vagifem |
| Progestins | Cycle regulation, HRT endometrial protection, pregnancy support | Provera (medroxyprogesterone), Aygestin (norethindrone), Duphaston (dydrogesterone), Gestanin (allylestrenol), Susten (progesterone) |
| Ovulation inducers | Anovulatory infertility (PCOS, unexplained); ovulation tracking | Clomid, Clofert, Fertomid (clomiphene), Femara (letrozole) |
| Dopamine agonists (prolactin) | Hyperprolactinaemia, prolactinoma, galactorrhea, lactation suppression | Dostinex (cabergoline), Parlodel (bromocriptine) |
| Bisphosphonates | Postmenopausal osteoporosis prevention and treatment | Fosamax (alendronate) |
| SERM (bone + breast) | Postmenopausal osteoporosis with breast cancer risk reduction interest | Evista (raloxifene) |
| Combined oral contraceptive | Backup contraception option; also see Birth Control category | Ovral-L |
| Female sexual dysfunction | Female sexual arousal disorder (off-label for many products) | Lovegra Oral Jelly, Femalefil |
| Other (supplements / specialty) | Breast support, other niche indications | Breast Success |
✅ How to Choose
- 💤 Bothersome menopausal hot flushes and night sweats (under age 60) → Estrace (estradiol) or transdermal estrogen + Provera if uterus intact. Annual review of risks/benefits.
- 🤰 Vaginal dryness/painful sex as predominant menopausal symptom → Vagifem (vaginal estradiol) twice weekly — minimal systemic exposure.
- 🥔 PCOS-related anovulatory infertility → Femara (letrozole) 2.5-7.5 mg days 3-7 often preferred over Clomid in PCOS; track ovulation.
- 🥔 Unexplained anovulatory infertility, normal weight → Clomid 50-150 mg days 5-9; refer to fertility specialist after 3-6 failed cycles.
- 💤 Elevated prolactin causing menstrual irregularity or galactorrhea → Dostinex (cabergoline) 0.25 mg twice weekly; gradual titration; monitor prolactin levels.
- 🦴 Postmenopausal osteoporosis (T-score under -2.5 or fragility fracture) → Fosamax (alendronate) 70 mg once weekly; take on empty stomach with full glass of water, remain upright 30 minutes.
- 🌹 Dysfunctional uterine bleeding (excluded structural cause) → Aygestin (norethindrone) 5-10 mg daily for 10-14 days to induce withdrawal bleed; or continuous low dose.
❓ Frequently Asked Questions about Women's Health
Is HRT safe?
For symptomatic women starting HRT within 10 years of menopause and under age 60, HRT is safe with favourable risk-benefit balance. Risks (small increases in breast cancer with combined HRT after 5+ years, thromboembolism with oral estrogen) are modest; benefits (symptom relief, bone protection, possibly cardiovascular and cognitive benefit in this early window) are substantial. Annual review; discontinue when symptoms have settled or risks outweigh benefits.
Should I use transdermal or oral estrogen?
Transdermal estrogen (patches, gels) bypasses first-pass liver metabolism, resulting in lower thromboembolic risk and minimal effect on triglycerides and clotting factors. Preferred in women with cardiovascular risk factors, history of clots, gallbladder disease, or migraine. Oral estrogen may be preferred for women with high cardiovascular risk factor profile where some "cardioprotective" effect on cholesterol metabolism is desired.
Does Clomid increase twin pregnancy chance?
Yes — Clomid increases twin pregnancy rate to approximately 5-10% (versus 1% spontaneous rate). Triplet or higher-order multiple pregnancies are rare but possible. Letrozole has lower multiple pregnancy rate (3-4%). Modern monitoring with ultrasound limits the risk of high-order multiples.
How long should I take bisphosphonates?
Standard duration is 3-5 years, then consider "drug holiday" for 1-2 years and reassess. Long-term bisphosphonate use (over 10 years) is associated with rare but serious complications (atypical femoral fracture, osteonecrosis of jaw). Drug holiday balances ongoing fracture prevention against these risks. High-risk patients may continue without break under specialist guidance.
Can I take HRT after breast cancer?
Systemic HRT is generally contraindicated after estrogen receptor-positive breast cancer. Hormone-receptor-negative breast cancer is theoretically less concerning but most oncologists advise against HRT. Vaginal estrogen may be considered for severe vaginal symptoms unresponsive to non-hormonal options — case-by-case decision with oncologist input.
What is the best progestin for HRT?
Choice depends on patient preference and side effect profile. Micronised progesterone (Susten) is generally well-tolerated with possible favourable effects on sleep. Dydrogesterone (Duphaston) has good acceptability with minimal androgenic side effects. Medroxyprogesterone (Provera) is the most-prescribed historically but may have unfavourable cardiovascular and breast cancer profile compared to micronised progesterone in some studies.
🩺 When to See a Healthcare Provider
Most women's health medications require gynaecology or endocrinology coordination: HRT initiation and ongoing review, fertility evaluation, hyperprolactinaemia workup, bone density screening from age 65 (or earlier with risk factors). Annual breast cancer screening (mammography), cervical cancer screening per local guidelines, and routine pelvic examination form the basis of preventive women's health care.
Seek prompt evaluation for: postmenopausal bleeding (any bleeding after 1 year of amenorrhea — rule out endometrial cancer), severe pelvic pain, breast lump or change, sudden severe headache, leg pain or swelling (possible DVT on HRT), chest pain with HRT use. Inform every prescriber and dentist about your women's health medications — significant interactions exist with anticoagulants, anticonvulsants, antibiotics, and many other classes.
📚 Related Articles
- 📖 Menstrual Cycle Back on Track: Hormonal Balance Restores Rhythm
- 📖 Menopause Symptom Relief: Practical Comfort, Clear Choices
- 📖 Navigating Menopause: Relief, Health and Lifestyle Tips
- 📖 Hormonal Balance Support
- 📖 Urinary Incontinence: Regaining Control and Confidence
- 📖 Lack of Orgasms in Women: Causes and What Actually Helps
- 🔗 Browse all RXshop articles
































